This part-time Master of Science in Pharmaceutical Medicine takes a multidisciplinary approach to the pharmaceutical sector, combining scientific foundations with hands-on, industry-relevant training. You will deepen your knowledge across the entire product lifecycle — from drug discovery and development to regulatory frameworks and strategies for bringing medicines to market — while learning directly from practicing industry professionals. The curriculum balances theory with practical application so you gain skills that are immediately useful in professional settings.
The programme is delivered in English and is structured to accommodate working professionals who want to advance their careers without pausing employment. It is particularly suited to those aiming for roles in clinical development, regulatory affairs, medical affairs, pharmacovigilance, or commercial functions within the pharmaceutical, biotech or regulatory sectors. Through industry engagement and applied projects, you will build a network and the practical experience needed to contribute to the development of safer, more effective medicines.
Application checklist — confirm exact requirements with the university:
For precise entry criteria, application deadlines, tuition details and document formats, consult the programme’s official admissions page or contact the admissions office directly.
Program overview
This MSc curriculum spans the full pharmaceutical value chain, giving you an interdisciplinary foundation that links basic science, clinical development and market access. Coursework emphasises how information and decisions move across the drug development lifecycle, from discovery and biopharmaceutical technologies through safety assessment and clinical testing to market entry. You will also undertake research projects that build practical skills valued in pharmaceutical companies, clinical research organisations and related sectors. The programme is delivered at Charlotte Fresenius University, part of the Carl Remigius Fresenius Education Group.
Learning outcomes and career relevance
Graduates will be able to interpret and integrate knowledge across preclinical and clinical phases, apply principles of clinical pharmacology and pharmacokinetics, and contribute to the design and management of clinical trials. Training in biostatistics, clinical data systems, drug safety and health economics prepares you to evaluate evidence, manage regulatory and ethical issues, and assess market access pathways. Overall the programme readies students for roles in drug development, clinical research, regulatory affairs, pharmacovigilance and health policy-related functions.
Core modules and topics you will encounter
Admissions (as stated in the original summary)
To qualify for admission you must hold an accredited Bachelor's degree in either medicine or a natural science with a minimum of 240 credit points. International applicants whose degree uses a different national credit system should contact the admissions office to confirm equivalence and documentation requirements.
You must demonstrate English language ability at CEFR level B2. Proof of your language level must be submitted as part of your application.
Applicants with more than one year of professional experience in the pharmaceutical sector may be considered for recognition of up to 30 credit points. Please get in touch with the programme team to learn how to apply for this credit and which documents are needed.
Admission requirements (summary)
Winter Semester (International)
Applications are possible all year round.
Graduates are prepared for professional roles across the pharmaceutical sector, including drug development, clinical trials management, regulatory affairs, pharmacovigilance/drug safety, clinical systems and data management, biostatistics, and health economics/market access. The programme’s industry-focused content and research projects equip students to take on specialist or leadership positions within pharmaceutical companies, contract research organisations, regulatory bodies, and consultancy firms.
Because the degree is designed for part-time learners with practical experience, it particularly benefits mid-career professionals seeking to advance into higher-responsibility roles or transition into adjacent functions such as clinical project management, regulatory strategy, or market access within the healthcare and life-science industries.